Home

NLS Pharmaceutics Ltd. - Warrant (NLSPW)

0.0048
+0.0003 (6.67%)
NASDAQ · Last Trade: Apr 28th, 11:16 PM EDT
QuoteNewsPress ReleasesChartHistorical
NLS Pharmaceutics CEO Highlights Progress And Plans For Advancing Rare CNS Disorder Therapies In Shareholder Letterbenzinga.com
NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) recently released a comprehensive shareholder letter by its CEO, Alex Zwyer, detailing recent achievements and ongoing endeavors.
Via Benzinga · August 28, 2023